Clinical Trials Logo

Clinical Trial Summary

A randomized trial of pregnant people at risk for postpartum depression comparing the InBloom app (n = 76) to ROSE (n = 76; weekly scheduled group), and two control groups. We will assess Depression at baseline and 1, 2 and 3 months, ROI at 3 months, Satisfaction at 1 and 3 months and Perceived Access at 1 and 3 months. Subject participation will last up to 8 months (minimum 17 weeks pregnant through 3 months postpartum).


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05518162
Study type Interventional
Source University of Rochester
Contact Tamara Bilinski
Phone 585-275-3138
Email tamara_bilinski@urmc.rochester.edu
Status Recruiting
Phase N/A
Start date July 17, 2023
Completion date July 1, 2025

See also
  Status Clinical Trial Phase
Recruiting NCT05077644 - Mobile Application in the Management of Mild to Moderate Postpartum Depression (PPD) N/A
Completed NCT01178008 - Pilot Study on the Use of Acupuncture for Postpartum Depression N/A
Active, not recruiting NCT03416010 - Healthy Lifestyle Intervention for High-Risk Minority Pregnant Women N/A
Withdrawn NCT02738021 - Managing PPD at Gouverneur N/A
Recruiting NCT06208852 - Virtual Patient Navigation During a Pandemic N/A
Withdrawn NCT02741206 - Preventing Postpartum Depression in Prenatal Care N/A
Completed NCT00373750 - Cradling Our Future Through Family Strengthening Study N/A
Not yet recruiting NCT06131255 - DRACULA1 Partum Depression: an Integrated Molecular-pharmaco-imaging Study")
Not yet recruiting NCT06285916 - A Study to Assess the Efficacy, Safety, and Tolerability of Oral NORA520 in Adults With Severe Postpartum Depression Phase 2
Completed NCT01407783 - Systems of Care for New Moms: Integrating Depression Treatment N/A